Azithromycin is a 15-membered macrolide antibiotic that has antibacterial effects on a variety of Gram-positive aerobic bacteria, Gram-negative aerobic bacteria, anaerobic bacteria, sexually transmitted disease microorganisms and other microorganisms. Its mechanism of action is the same as that of erythromycin, mainly binding to the 50S subunit of bacterial ribosomes and inhibiting RNA-dependent protein synthesis.

This product is a component of parenteral nutrition, which can be decomposed into glutamine and alanine in the body, and supplemented with glutamine through parenteral nutrition infusion. This product can be used for parenteral nutrition support for diseases that may cause glutamine depletion in the body.

This product is a component of parenteral nutrition and can be decomposed into glutamine and alanine in the body. Its characteristics can be used to supplement glutamine through parenteral nutrition infusion. The amino acids released by the decomposition of this dipeptide are stored in the corresponding parts of the body as nutrients and metabolized according to the needs of the body. This product can be used for parenteral nutrition support for diseases that may cause glutamine depletion in the body.

This product acts specifically on the gastric mucosal parietal cells, reducing the activity of H/KATPase in the parietal cells, thereby inhibiting the secretion of gastric acid. Compared with omeprazole and lansoprazole, this product has a weaker inhibitory effect on cytochrome P450-dependent enzymes. No adverse effects were found in either short-term or long-term administration of pantoprazole. This drug is non-carcinogenic, does not impair fertility, and does not induce teratogenesis. After 2.5 years of continuous medication, there were no changes in various experimental parameters of liver enzymology and cholesterol metabolism.

This product acts specifically on the gastric mucosal parietal cells, reducing the activity of H/KATPase in the parietal cells, thereby inhibiting the secretion of gastric acid. Compared with omeprazole and lansoprazole, this product has a weaker inhibitory effect on cytochrome P450-dependent enzymes. No adverse effects were found in either short-term or long-term administration of pantoprazole. This drug is non-carcinogenic, does not impair fertility, and does not induce teratogenesis. After 2.5 years of continuous medication, there were no changes in various experimental parameters of liver enzymology and cholesterol metabolism.